We are live on ! Find out more
JPMIA

J.P. Marvel Investment Advisors Portfolio holdings

AUM $705M
1-Year Est. Return 43.01%
This Fund
S&P 500
This Quarter Est. Return
+11.2%
1 Year Est. Return
+43.01%
3 Year Est. Return
+140.86%
5 Year Est. Return
+213.54%
10 Year Est. Return
AUM
$479M
AUM Growth
+$35.8M
Cap. Flow
-$2.5M
Cap. Flow %
-0.52%
Top 10 Hldgs %
48.39%
Holding
71
New
Increased
7
Reduced
41
Closed
1

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$474K
2
AMZN icon
Amazon
AMZN
+$125K
3
F icon
Ford
F
+$110K
4
MRNA icon
Moderna
MRNA
+$78K
5
AMD icon
Advanced Micro Devices
AMD
+$35.4K

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$1.05M
2
NVDA icon
NVIDIA
NVDA
+$317K
3
PFE icon
Pfizer
PFE
+$307K
4
MS icon
Morgan Stanley
MS
+$203K
5
AAPL icon
Apple
AAPL
+$159K

Sector Composition

Rank Sector Weight
1 Technology 29.97%
2 Healthcare 29.66%
3 Financials 11.88%
4 Industrials 6.76%
5 Communication Services 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.99T
$40.9M 8.53%
210,611
-910
-0.4% -$159K
NVDA icon
2
NVIDIA
NVDA
$4.8T
$37.9M 7.91%
896,050
-9,550
-1% -$317K
LLY icon
3
Eli Lilly
LLY
$1.09T
$26.4M 5.52%
56,380
-60
-0.1% -$25.2K
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.07T
$24.6M 5.13%
205,560
-900
-0.4% -$104K
TMO icon
5
Thermo Fisher Scientific
TMO
$214B
$20.5M 4.27%
39,213
-205
-0.5% -$111K
AMZN icon
6
Amazon
AMZN
$2.48T
$17.6M 3.68%
135,237
+1,097
+0.8% +$125K
MS icon
7
Morgan Stanley
MS
$333B
$17.5M 3.64%
204,493
-2,373
-1% -$203K
JPM icon
8
JPMorgan Chase
JPM
$947B
$16.2M 3.37%
111,161
-434
-0.4% -$59.7K
MSFT icon
9
Microsoft
MSFT
$2.96T
$15.2M 3.18%
44,717
-266
-0.6% -$83.4K
V icon
10
Visa
V
$697B
$15.1M 3.16%
63,669
-253
-0.4% -$57.9K
ABBV icon
11
AbbVie
ABBV
$468B
$11.5M 2.4%
85,430
-460
-0.5% -$67.5K
BMY icon
12
Bristol-Myers Squibb
BMY
$130B
$11.4M 2.39%
178,864
-427
-0.2% -$28.6K
DE icon
13
Deere & Co
DE
$172B
$11.3M 2.35%
27,836
JNJ icon
14
Johnson & Johnson
JNJ
$649B
$11.2M 2.33%
67,459
-370
-0.5% -$59.7K
LRCX icon
15
Lam Research
LRCX
$337B
$10.8M 2.26%
168,120
CSCO icon
16
Cisco
CSCO
$461B
$9.67M 2.02%
186,898
-550
-0.3% -$27.1K
GLW icon
17
Corning
GLW
$104B
$8.96M 1.87%
255,590
-2,190
-0.8% -$72K
EOG icon
18
EOG Resources
EOG
$74.3B
$8.23M 1.72%
71,890
-520
-0.7% -$59.4K
CRL icon
19
Charles River Laboratories
CRL
$11.4B
$8.16M 1.7%
38,802
+2,380
+7% +$474K
BAC icon
20
Bank of America
BAC
$439B
$7.96M 1.66%
277,584
-1,218
-0.4% -$34.8K
AKAM icon
21
Akamai
AKAM
$16.3B
$7.92M 1.65%
88,159
-522
-0.6% -$44.7K
PFE icon
22
Pfizer
PFE
$144B
$7.83M 1.63%
213,359
-7,889
-4% -$307K
DHR icon
23
Danaher
DHR
$141B
$7.66M 1.6%
36,025
-68
-0.2% -$14.4K
ABT icon
24
Abbott
ABT
$188B
$7.65M 1.6%
70,148
-400
-0.6% -$42.6K
SHW icon
25
Sherwin-Williams
SHW
$87.2B
$7.05M 1.47%
26,567
-125
-0.5% -$29.4K

Similar funds

J.P. Marvel Investment Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, J.P. Marvel Investment Advisors held 71 positions worth $479M, up 8.1% from $443M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 1.4%. J.P. Marvel Investment Advisors opened no new positions and exited 1, leaving the 71-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • J.P. Marvel Investment Advisors added most to Charles River Laboratories in Q2 2023, an estimated $474K increase.
  • J.P. Marvel Investment Advisors's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $317K.
  • J.P. Marvel Investment Advisors fully exited Goldman Sachs in Q2 2023, selling an estimated $1.05M.
  • J.P. Marvel Investment Advisors's ten largest holdings make up 48% of its $479M portfolio in Q2 2023.
  • J.P. Marvel Investment Advisors opened 0 new positions and closed 1 in Q2 2023.
  • J.P. Marvel Investment Advisors's portfolio value rose 8.1% quarter-over-quarter to $479M.

Based on J.P. Marvel Investment Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.